News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
A retrospective study in EGFR+ NSCLC with brain metastases – Clinical Lung Cancer
utsouthwestern.edu
Feb 4, 2025, 16:58

A retrospective study in EGFR+ NSCLC with brain metastases – Clinical Lung Cancer

Clinical Lung Cancer shared a post on X about a recent paper by Wesley Wong et al. published in Clinical Lung Cancer:

“A retrospective study in EGFR+ NSCLC with brain metastases shows that continuing osimertinib and chemo after progression reduces CNS progression vs. chemo alone.

CNS-PFS was longer (9.0 vs. 5.7 months), and salvage brain RT rates were lower (15% vs. 24%).”

“CNS outcomes of osimertinib plus chemotherapy in patients with EGFR mutation positive lung cancer beyond osimertinib progression”

Authors: Wesley Wong, Kevin Mok, Giselle Tsui, Tony Mok, Molly Li et al.

A retrospective study in EGFR+ NSCLC with brain metastases - Clinical Lung Cancer

More posts featuring Clinical Lung Cancer.

cancer Clinical Lung Cancer EGFR+ NSCLC Giselle Tsui Kevin Mok Molly Li OncoDaily Oncology Tony Mok Wesley Wong
Special Coverage
Blog
Mar 10, 2025, 09:36
Sakditad Saowapa: Great catch and inspiring discussions at JSMO25
Insight
Mar 10, 2025, 09:32
Douglas Flora: Starting the Volume 2 of AI in Precision Oncology
Blog
Mar 10, 2025, 09:27
Roberto Iacovelli has received an Impact Award from European Urology Journal for the Tide-A Phase 2 study
Science
Mar 10, 2025, 09:12
Myeloma Paper of the Day, March 10th, suggested by Robert Orlowski
Blog
Mar 10, 2025, 08:54
Martin Kaiser: Co-occurrence of more than 2 HRCAs is associated with highest unmet need in NDMM and RRMM
Blog
Mar 10, 2025, 08:53
Nina Niu Sanford: 73 Questions with Dr. Bob Timmerman
Blog
Mar 10, 2025, 08:40
The Cancer Survivorship Group of Danish Cancer Institute
Blog
Mar 10, 2025, 08:34
The countdown is on for Women Leaders in Oncology 2025 - Vaniam Group
Blog
Mar 10, 2025, 08:32
Bishal Gyawali: Surrogate endpoints in cancer drug trials
Blog
Mar 10, 2025, 08:25
Prerna Mewawalla: Real-world outcomes of sequential BCMA-directed therapy in Multiple Myeloma
Science
Mar 10, 2025, 08:17
Does minimally invasive pancreatoduodenectomy offer real advantages? - SSO
Blog
Mar 10, 2025, 08:14
Peter Pisters: An inspiring evening at 'A Conversation With a Living Legend' event